SS-31 (elamipretide)
Also called Bendavia
A peptide that targets mitochondria, approved in the US in 2025 for the rare disease Barth syndrome.
- Usual amount
- 5–40 mg commonly reported
- How it’s taken
- Injection under the skin
- Good after mixing
- 28 days in the fridge
Track this in StackbaseFree. Your doses, streaks and supplies in one private place.
What it is
SS-31 binds to cardiolipin, a fat in the inner membrane of mitochondria, and helps them make energy with less oxidative stress. As elamipretide it received accelerated approval in the US in 2025 for Barth syndrome, a rare genetic disease. Other uses, like healthy aging, are experimental.
How it’s used
- Injected under the skin once a day.
Typical amounts
- The approved dose for Barth syndrome is 40 mg once a day.
- Off-label amounts are often much lower; there is no established dose for other uses.
Good to know
- Injection-site reactions (redness, itching, pain) are very common.
- Outside Barth syndrome, the evidence is limited.
Educational information, not medical advice. Check anything you take with a doctor or pharmacist.